Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties

Two new series of thiazole and formazan linked to 5-Bromo-indan were synthesized, and their structures were assured based on all possible analytical techniques. The size of the tested derivatives was calculated from the XRD technique and found five derivatives 3, 10a, 14a, 15, and 16 on the nanosize...

Full description

Bibliographic Details
Main Authors: Ghaidaa H. Alfaifi, Thoraya A. Farghaly, Magda H. Abdellattif
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977057/?tool=EBI
_version_ 1811160131910500352
author Ghaidaa H. Alfaifi
Thoraya A. Farghaly
Magda H. Abdellattif
author_facet Ghaidaa H. Alfaifi
Thoraya A. Farghaly
Magda H. Abdellattif
author_sort Ghaidaa H. Alfaifi
collection DOAJ
description Two new series of thiazole and formazan linked to 5-Bromo-indan were synthesized, and their structures were assured based on all possible analytical techniques. The size of the tested derivatives was calculated from the XRD technique and found five derivatives 3, 10a, 14a, 15, and 16 on the nanosized scale. The two series were tested for their efficacy and toxicity as anti-colon and stomach cancers. Derivative 10d showed activity more than the two reference drugs used in the case of SNU-16. Surpislly, in the case of COLO205, five derivatives 4, 6c, 6d, 6e, and 10a are better than the two benchmarks used, and two derivatives, 14a and 14b more potent than cisplatin. All potent derivatives showed a strong fit with the active site of the two tested proteins (gastric cancer (PDB = 2BID) and colon cancer (PDB = 2A4L)) in the molecular docking study. The Pharmacophore and ADME studies of the new derivatives showed that most derivatives revealed promising bioactivity, which indicates the drug-likeness properties against kinase inhibitors, protease, and enzyme inhibitors. In addition, the ProTox-II showed that the four compounds 10d, 16, 6d, and 10a are predicted to have oral LD50 values ranging from 335 to 3500 mg/kg in a rat model with (1 s,4 s)-Eucalyptol bearing the highest values and quercetin holding the lowest one.
first_indexed 2024-04-10T05:52:50Z
format Article
id doaj.art-5a6388686c6d4e1d85e19bc0b814d602
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-10T05:52:50Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5a6388686c6d4e1d85e19bc0b814d6022023-03-04T05:31:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01183Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration propertiesGhaidaa H. AlfaifiThoraya A. FarghalyMagda H. AbdellattifTwo new series of thiazole and formazan linked to 5-Bromo-indan were synthesized, and their structures were assured based on all possible analytical techniques. The size of the tested derivatives was calculated from the XRD technique and found five derivatives 3, 10a, 14a, 15, and 16 on the nanosized scale. The two series were tested for their efficacy and toxicity as anti-colon and stomach cancers. Derivative 10d showed activity more than the two reference drugs used in the case of SNU-16. Surpislly, in the case of COLO205, five derivatives 4, 6c, 6d, 6e, and 10a are better than the two benchmarks used, and two derivatives, 14a and 14b more potent than cisplatin. All potent derivatives showed a strong fit with the active site of the two tested proteins (gastric cancer (PDB = 2BID) and colon cancer (PDB = 2A4L)) in the molecular docking study. The Pharmacophore and ADME studies of the new derivatives showed that most derivatives revealed promising bioactivity, which indicates the drug-likeness properties against kinase inhibitors, protease, and enzyme inhibitors. In addition, the ProTox-II showed that the four compounds 10d, 16, 6d, and 10a are predicted to have oral LD50 values ranging from 335 to 3500 mg/kg in a rat model with (1 s,4 s)-Eucalyptol bearing the highest values and quercetin holding the lowest one.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977057/?tool=EBI
spellingShingle Ghaidaa H. Alfaifi
Thoraya A. Farghaly
Magda H. Abdellattif
Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties
PLoS ONE
title Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties
title_full Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties
title_fullStr Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties
title_full_unstemmed Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties
title_short Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties
title_sort indenyl thiazole and indenyl formazan derivatives synthesis anticancer screening studies molecular docking and pharmacokinetic molin spiration properties
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977057/?tool=EBI
work_keys_str_mv AT ghaidaahalfaifi indenylthiazoleandindenylformazanderivativessynthesisanticancerscreeningstudiesmoleculardockingandpharmacokineticmolinspirationproperties
AT thorayaafarghaly indenylthiazoleandindenylformazanderivativessynthesisanticancerscreeningstudiesmoleculardockingandpharmacokineticmolinspirationproperties
AT magdahabdellattif indenylthiazoleandindenylformazanderivativessynthesisanticancerscreeningstudiesmoleculardockingandpharmacokineticmolinspirationproperties